Completed NA INTERVENTIONAL 3-arm NCT05070637

Circulating Tumor Cell Reducing No-touch Nephrectomy (CITO-CERENE)

No-touch Radical Nephrectomy Technique Reduces Circulating Tumor Cell Release in Renal Cell Carcinoma Patients - a Randomized Controlled Trial

Sponsor: Centro Hospitalar Lisboa Norte

Conditions Circulating Tumor Cell Renal Cell Carcinoma

Interventions Conventional laparoscopic radical nephrectomy Laparoscopic total nephrectomy control arm No-touch laparoscopic radical nephrectomy

Updated 5 times since 2021 Last updated: Nov 10, 2022 Started: Sep 27, 2021 Primary completion: May 18, 2022 Completion: May 18, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Circulating Tumor Cell and Renal Cell Carcinoma, this trial is completed. The trial is conducted by Centro Hospitalar Lisboa Norte and has accumulated 5 data snapshots since 2021. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Nov 2021 — Dec 2022 [monthly]

Recruiting NA

First recorded

Sep 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centro Hospitalar Lisboa Norte
Hospital de Santa Maria, Portugal
Instituto de Medicina Molecular João Lobo Antunes

Data source: Hospital de Santa Maria, Portugal

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lisbon, Portugal